Светлый фон

9. Salif Sow P., Ward S. Reinventing the condom. Impatient Optimists. Available at: https://www.impatientoptimists.org/Posts/2013/03/Reinventing-The-Condom#.XOXnHfZFw6Y. Accessed May 22, 2019.

Impatient Optimists.

10. Harrington E. Origami con man. Washington Beacon. May 1, 2014. Available at: https://freebeacon.com/issues/origami-con-man/. Accessed May 30, 2019.

Washington Beacon.

11. Harrington E. Origami Condom inventor has to pay back taxpayer funds. Washington Beacon. May 1, 2014. https://freebeacon.com/issues/origami-condom-inventor-has-to-pay-back-taxpayer-funds/. Accessed May 30, 2019.

Washington Beacon.

12. Taylor J. 2 years later, here’s what happened to Bill Gates’ condoms of the future. Mic. November 18, 2015. Available at: https://www.mic.com/articles/128850/bill-and-melinda-gates-foundation-condom-contest-where-are-they-now. Accessed June 1, 2019.

Mic

13. Kaler A. The female condom in North America: selling the technology of ‘empowerment.’ J Gend Stud. 2004;13(2):139–52. doi: 10.1080/0958923042000217819.

J Gend Stud.

14. Anthes E. The future of sex? Mosaic. March 4, 2014. Available at: https://mosaicscience.com/story/future-sex/. Accessed May 30, 2019.

Mosaic.

15. Guerrero D. Internal condoms become prescription only. Plus. June 6, 2017. https://www.hivplusmag.com/prevention/2017/6/16/internal-condoms-become-prescription-only. Accessed June 1, 2019.

Plus.

16. Food and Drug Administration. Obstetrical and gynecological devices; reclassification of single-use female condom, to be renamed single-use internal condom. Federal Register. September 27, 2018. Available at: https://www.federalregister.gov/documents/2018/09/27/2018-21044/obstetrical-and-gynecological-devices-reclassification-of-single-use-female-condom-to-be-renamed. Accessed May 22, 2019.

17. Rogers K. Why are condoms still a thing? Vice. February 13, 2015. Available at: https://www.vice.com/enus/article/mgbx4x/why-are-condoms-still-a-thing. Accessed June 1, 2019.

Vice.

18. Bolan R. K., Beymer M. R., Weiss R. E., Flynn R. P., Leibowitz A. A., Klausner J. D. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Sex Transm Dis. 2015 Feb;42(2):98–103.

Sex Transm Dis.

19. Molina J. M., Charreau I., Chidiac C., Pialoux G., Cua E., Delaugerre C., Capitant C., Rojas-Castro D., Fonsart J., Bercot B., Bébéar C., Cotte L., Robineau O., Raffi F., Charbonneau P., Aslan A., Chas J., Niedbalski L., Spire B., Sagaon-Teyssier L., Carette D., Mestre S. L., Doré V., Meyer L.; ANRS IPERGAY Study Group. Postexposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis. 2018 Mar;18(3):308–17. doi: 10.1016/S1473-3099(17)30725-9. Epub 2017 Dec 8. PubMed PMID: 29229440.